IonQ's stock is projected to drop 16.65% to $43.82 over the next 12 months despite a 755% revenue increase and raised guidance to $260-$270 million for 2026. The company shows strong commercial growth and government contracts, but faces risks from high cash burn, significant stock-based compensation dilution, and a very high valuation with a 138x price-to-sales ratio. Analysts remain mostly bullish with a consensus target of $63.91, but the current price is considered overvalued given the ongoing losses and execution risks. The outlook depends on commercial revenue growth and reduced cash burn, with potential upside from federal investment or successful 256-qubit system deployment.
